Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening-Reference-Cited by-同舟云学术

Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening

Published:2018-04-16 Issue:6 Volume:38 Page:1874-1915
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med Res Rev

Author:

Ojeda-Montes María José¹,Gimeno Aleix¹,Tomas-Hernández Sarah¹,Cereto-Massagué Adrià¹,Beltrán-Debón Raúl¹,Valls Cristina¹,Mulero Miquel¹,Pujadas Gerard¹²^ORCID,Garcia-Vallvé Santiago¹²

Affiliation:

1. Research Group in Cheminformatics & Nutrition, Departament de Bioquímica i Biotecnologia; Universitat Rovira i Virgili; Campus de Sescelades; Tarragona Spain

2. EURECAT, TECNIO, CEICS; Avinguda Universitat 1; Reus Spain

Funder

Agència de Gestió d’Ajuts Universitaris i de Recerca

Programa de Foment de la Recerca (URV)

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/med.21499/fullpdf

Reference213 articles.

1. A comprehensive review of the FDA-approved labels of diabetes drugs: indications, safety, and emerging cardiovascular safety data;Gourgari;J Diabetes Complications,2017